483
National Cancer Institute Central IRBFDA 483 - National Cancer Institute Central IRB - August 09, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of the National Cancer Institute Central IRB in Rockville, MD, revealed a significant procedural lapse. The Institutional Review Board failed to update its registration information regarding changes in chairperson within the required 90-day timeframe. This resulted in delays of 467 and 106 days for two separate IRB committees.
Open in Dashboard
ID · 34541808-bed8-418e-862d-d3b4628a3d0b